UroGen Pharma last closed at $41.43 (-3.16%) on 2026-10-06. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -21.4×. Its overall grade ranks 2 of 740 stocks in Healthcare.
About this company
UroGen Pharma last closed at $41.43 (-3.16%) on 2026-10-06. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A+ · 2/740
Valuation grade A-
Related stocks
- Astellas PharmaCustomer
UGN-102 공동개발/상업화 파트너
- Johnson & JohnsonCompetitor
비뇨기암·비뇨기과 치료제 분야 대형 제약 경쟁사
- AstraZenecaCompetitor
비뇨기암 치료 영역에서 경쟁하는 글로벌 제약사
ETFs holding this stock
iShares Micro-Cap ETF
Details →About UroGen Pharma
- What technical signals does UroGen Pharma (URGN) have?
- UroGen Pharma current technical signals: MACD bullish cross.
- Is UroGen Pharma a cup-and-handle pattern?
- No. UroGen Pharma has no valid Cup signal right now.
- What published figures are available for UroGen Pharma?
- Market cap: $1.94B. Trailing 12 months PER: -21.4×. Latest quarter PBR: -15.77×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-07 dataset
Turn what you saw on this name into a strategy
Ask Q about UroGen Pharma, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy